On September 6, 2019 Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, reported that Stanley C. Erck, President and Chief Executive Officer, will present at the H. C. Wainwright 21st Annual Global Investment Conference (Press release, Novavax, SEP 6, 2019, View Source [SID1234539346]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are as follows:

Date and Time: Tuesday, September 10, 11:15 a.m. – 11:40 a.m. E.T.
Location: Holmes II, Lotte New York Palace Hotel, New York
Live webcast: www.novavax.com, "Investors"/"Events"
A replay of the presentation will also be accessible under the "Investors/Events" section www.novavax.com.